SCHEMBL3679869

SCHEMBL3679869

O=C(CCN1CCN(Cc2c[nH]cn2)c2ccc(-c3ccccc3)cc2C1)S(=O)(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FNTA P49354 11/20 0.39
FNTB P49356 11/20 0.39
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
BACE1 P56817 1/20 0.32
HDAC1 Q13547 1/20 0.31
TNIK Q9UKE5 1/20 0.31
LMNA P02545 1/20 0.31
SLC2A1 P11166 1/20 0.31
MLNR O43193 1/20 0.31
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31
HTR6 P50406 1/20 0.31
GHSR Q92847 1/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3694212 0.84 FNTA (0.41) FNTAFNTBALDH1A1KDM4ELMNA
SCHEMBL3500964 0.84 FNTA (0.41) FNTAFNTBALDH1A1KDM4EMAPT
SCHEMBL3500345 0.81 FNTA (0.50) FNTAFNTBALDH1A1KDM4EMAPT
SCHEMBL3501379 0.80 FNTA (0.44) FNTAFNTBALDH1A1TSHR
SCHEMBL3501375 0.79 FNTA (0.44) FNTAFNTB
SCHEMBL3501004 0.79 FNTA (0.49) FNTAFNTBCYP11B1CYP11B2
SCHEMBL3502482 0.78 FNTA (0.52) FNTAFNTBALDH1A1KDM4EMAPT
SCHEMBL3501599 0.78 FNTA (0.41) FNTAFNTBHDAC1LMNACYP11B1
SCHEMBL3502109 0.78 FNTA (0.51) FNTAFNTBKDM4ECYP11B1CYP11B2
SCHEMBL3502072 0.77 FNTA (0.46) FNTAFNTBALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010057028-A9 TREATMENT OF PROTEINOPATHIES USING A FARNESYL TRANSFERASE INHIBITOR LINK MEDICINE CORPORATION (US) 2010-09-02 WO disclosed